2025中国细胞与基因治疗大会召开

Core Insights - The 2025 China Cell and Gene Therapy Conference (CSGCT) was held in Beijing, focusing on the theme "Global Market, Chinese Power" and aimed at fostering international collaboration in the cell and gene therapy (CGT) sector [1][2] - Beijing's medical health industry reached a scale of 1.06 trillion yuan in 2024, marking an 8.7% year-on-year growth, making it the first city in China to surpass the trillion yuan mark in this sector [1] Group 1 - The conference attracted nearly 2,000 attendees, including over 10 international leaders in CGT, scientists, clinicians, entrepreneurs, and investors [1] - The establishment of the CSGCT China Cell and Gene Therapy Alliance aims to create an international platform for scientific research and collaboration in the CGT field [2] - The conference released a blue paper on the development and regulatory policies of the CGT industry, facilitating authoritative dialogue between the industry and regulators [2] Group 2 - The conference featured 15 sub-forums covering various cutting-edge topics such as gene therapy, immune cell therapy, stem cells, gene editing, and tumor vaccines, as well as key industry chain aspects like CMC and regulatory affairs [3] - Specific sub-forums focused on CNS diseases, ophthalmology, cardiovascular metabolic diseases, and significant directions in tumor and autoimmune diseases [3] - Two project roadshows were organized to connect innovative companies with international capital, with participation from well-known investment institutions like Eli Lilly Asia Fund and Junlian Capital [3]